# CStone Pharmaceuticals Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cstone-pharmaceuticals-co

- Industry: Pharmaceuticals
- Headquarters: Suzhou, China
- Website: www.cstonepharma.com
- Total disclosed funding: $410M
- Latest round: Series B (May 8, 2018)
- Investors on record: 14

## About

Founded in 2015 and based in Suzhou, China, CStone Pharmaceuticals Co., Ltd. researches and develops biopharmaceutical therapeutics focused on immuno-oncology and molecular targeting for treating cancer.

## Funding rounds

- Series B, May 8, 2018, $260M — ARCH Venture Partners, Hong Shan, GIC, CPE Funds Management, Oriza Holdings, Taikang Life, YF Capital, Boyu Capital, Hillhouse Investment, 6 Dimensions Capital, 3W Partners, 6 Dimensions Capital, AVICT Global Holdings, King  Star Capital, Terra Magnum Capital Partners
- Series A, Jul 3, 2016, $150M — Oriza Holdings, Boyu Capital, 6 Dimensions Capital

## Investors

- Oriza Holdings (https://capitalatlas.ai/funds/oriza-holdings) — Series A, Series B
- Boyu Capital (https://capitalatlas.ai/funds/boyu-capital) — Series A, Series B
- 6 Dimensions Capital (https://capitalatlas.ai/funds/6-dimensions-capital) — Series A, Series B
- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series B
- Hong Shan — Series B
- GIC — Series B
- CPE Funds Management (https://capitalatlas.ai/funds/cpe-funds-management) — Series B
- Taikang Life — Series B
- YF Capital (https://capitalatlas.ai/funds/yf-capital) — Series B
- Hillhouse Investment (https://capitalatlas.ai/funds/hillhouse-investment) — Series B
- 3W Partners (https://capitalatlas.ai/funds/3w-partners) — Series B
- AVICT Global Holdings — Series B
- King  Star Capital — Series B
- Terra Magnum Capital Partners (https://capitalatlas.ai/funds/terra-magnum-capital-partners) — Series B